title: Budget Impact Analysis Of Biphasic Insulin Aspart In The Treatment Of Type 2 Diabetes Mellitus In Malaysia: A Public Payer Perspective.
authors.affiliation: IMS Asia Pacific, Singapore.
authors.forename: S C
authors.initials: SC
authors.lastname: Tan
authors.affiliation: Novo Nordisk Pharma Malaysia, Kuala Lumpur, Malaysia.
authors.forename: P
authors.initials: P
authors.lastname: Matzen
authors.affiliation: Novo Nordisk Pharma Malaysia, Kuala Lumpur, Malaysia.
authors.forename: L N
authors.initials: LN
authors.lastname: Yeo